Factors predicting the sentinel and non-sentinel lymph node metastases in breast cancer V. OzmenH. Karanlik A. Mudun Clinical trial 02 December 2005 Pages: 1 - 6
Breast tumors that overexpress nuclear metastasis-associated 1 (MTA1) protein have high recurrence risks but enhanced responses to systemic therapies Michelle D. MartinSusan G. HilsenbeckPeter O’Connell OriginalPaper 22 October 2005 Pages: 7 - 12
Genotypic and allelic frequencies of SULT1A1 polymorphisms in women receiving adjuvant tamoxifen therapy J.L. GrabinskiL.S. SmithJ.G. Kuhn OriginalPaper 30 November 2005 Pages: 13 - 16
Compensatory ErbB3/c-Src signaling enhances carcinoma cell survival to ionizing radiation Joseph N. ContessaAngela AbellRupert K. Schmidt-Ullrich OriginalPaper 03 November 2005 Pages: 17 - 27
Breast cancer risk assessment in the Czech female population – an adjustment of the original Gail model Jan NovotnyLadislav PecenMiloslava Skovajsova Epidemiology 01 December 2005 Pages: 29 - 35
Activation of vascular endothelial growth factor (VEGF) by the ER-α variant, ERΔ3 Sailaja KoduriAnita S. GoldharBarbara K. Vonderhaar OriginalPaper 03 November 2005 Pages: 37 - 43
Multicenter phase II study of trastuzumab in combination with epirubicin and docetaxel as first-line treatment for HER2-overexpressing metastatic breast cancer M. VenturiniC. BighinL. Del Mastro Clinical trial 03 November 2005 Pages: 45 - 53
A French national survey on infiltrating breast cancer: analysis of clinico-pathological features and treatment modalities in 1159 patients Bruno CutuliPaul Henri CottuRosemary Jourdan Epidemiology 27 October 2005 Pages: 55 - 64
Polymorphisms of the promoter regions of matrix metalloproteinases genes MMP-1 and MMP-9 in breast cancer Karolina PrzybylowskaAnita KlucznaJanusz Blasiak OriginalPaper 03 November 2005 Pages: 65 - 72
Polymorphisms of the DNA repair genes XPD (Lys751Gln) and XRCC1 (Arg399Gln and Arg194Trp): relationship to breast cancer risk and familial predisposition to breast cancer A.M. BrewsterT.J. JorgensenK.J. Helzlsouer OriginalPaper 01 December 2005 Pages: 73 - 80
Incidence of BRCA1 and BRCA2 mutations in 54 Chilean families with breast/ovarian cancer, genotype–phenotype correlations Marcela GallardoAntonia SilvaPilar Carvallo Epidemiology 27 October 2005 Pages: 81 - 87
The effect of race/ethnicity and insurance in the administration of standard therapy for local breast cancer in Florida Lydia VotiLisa C. RichardsonJan Willem W. Coebergh Epidemiology 22 October 2005 Pages: 89 - 95
Can the apparent conflicting roles of PKC δ on cell proliferation and survival be reconciled? Emanuela MaioliFortino Vittoria Letter to the editor 01 December 2005 Pages: 97 - 98